Matthew Lammi

Matthew Lammi is a Senior Professor at Louisiana State University Health Sciences Center, New Orleans. His research focuses on pulmonary arterial hypertension (PAH), cardiology, and respiratory medicine, with particular emphasis on risk prediction, echocardiographic stress testing, and medication adherence in PAH. His recent work includes refining risk stratification in systemic sclerosis-associated PAH, evaluating the dual benefits of bosentan, and integrating patient-reported outcomes into survival prediction models. He also investigates proteomic biomarkers, such as angiotensin-converting enzyme 2, in relation to right ventricular function, and explores lung manifestations in idiopathic inflammatory myopathies. His publications appear in leading journals including the American Journal of Respiratory and Critical Care Medicine and the Journal of the American Society of Echocardiography.